Trial Profile
A phase 3, non-blind, multicenter study of M512101 in patients with superficial dermatological infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Ozenoxacin (Primary)
- Indications Dermatitis
- Focus Therapeutic Use
- Sponsors Maruho
- 04 Dec 2015 New trial record